Veeva Systems Q2 FY2026 Earnings Call Summary

VEEV NYSE Technology 📅 2026-08-26 ⏱ ~60 sec read 🟢 Bullish

⏱️ 60-Second Brief Veeva Systems · Q2 FY2026

Stock Next Day

▲ 15.2%

$244.91 → $282.13

Revenue

$928.0M

✅ Beat

EPS

$1.66

✅ Beat

AI Sentiment

🟢 Bullish

The company delivered strong financial results, exceeded gui…

📌 Bottom Line: Veeva Systems reported an exceptionally strong second quarter, surpassing revenue and earnings expectations with an 18% year-over-year growth in total revenues to $928.0 million and diluted EPS of $1.66. This robust perf…

🤖 AI-Assisted Summary — Produced using a custom AI pipeline by Abhi, reviewed for accuracy. · ⚠️ Not financial advice. For informational purposes only. Full Disclaimer →

✍️ EarningsBloom Editorial Team · 📅 Last updated: 2026-08-28 · 📎 Source: SEC EDGAR / Company Press Release

📋 TL;DR — What Happened

Veeva Systems reported an exceptionally strong second quarter, surpassing revenue and earnings expectations with an 18% year-over-year growth in total revenues to $928.0 million and diluted EPS of $1.66. This robust performance, fueled by significant advancements in AI and expanding customer adoption across its Vault CRM and R&D solutions, positions the company for continued leadership in the life sciences cloud market.

📊 Key Financial Metrics

Revenue $928.0M ✅ Beat

EPS (Diluted) $1.66 ✅ Beat

YoY Revenue Growth 18%

Gross Margin 75.0%

Net Income $273.4M

AI Sentiment 🟢 Bullish The company delivered strong financial results, exceeded guidance, and demonstrated significant progress in AI innovation and customer adoption, indicating robust future growth potential.

✅ What Went Well

✅ **Robust Financial Growth**: Veeva reported total revenues of $928.0 million, an 18% increase year-over-year, significantly beating expectations. This strong top-line growth was accompanied by a healthy net income of $273.4 million and a solid gross margin of 75.0%, demonstrating efficient operations and profitability.

✅ **Accelerated AI Leadership**: The company highlighted major strides in its artificial intelligence offerings, with Veeva Falcon accelerating rapidly towards initial go-lives this year and Vault AI achieving significant milestones through new standard agents and advanced custom development capabilities. The acquisition of Copli further strengthens its AI portfolio.

✅ **Deepening Customer Relationships and Market Penetration**: Vault CRM experienced its "best quarter ever," securing commitments from 12 top 20 biopharmas globally and expanding its live customer base. Additionally, Veeva Safety surpassed 100 customers, including a second top 20 biopharma win, showcasing broad adoption across its R&D and Quality solutions.

⚠️ Concerns & Risks

⚠️ **Reliance on Non-GAAP Metrics**: While common in the tech industry, Veeva's heavy emphasis on non-GAAP financial measures for reporting and guidance, particularly for operating income and EPS, can make it challenging for some investors to fully reconcile with GAAP performance and understand the impact of non-cash expenses like stock-based compensation.

⚠️ **Pace of Widespread AI Adoption**: Despite rapid advancements and "early adopters" for new AI platforms like Veeva Falcon, the transition from early adoption to broad, enterprise-wide implementation across the entire customer base could be a gradual process, potentially impacting the immediate revenue contribution from these innovative solutions.

⚠️ **Intensifying Competitive Landscape**: As AI becomes a more critical component of life sciences technology, the competitive environment could intensify. While Veeva is a leader, maintaining its edge will require continuous, substantial investment in research and development to innovate faster than new entrants or existing competitors enhancing their own AI capabilities.

🔮 CEO / Management Guidance

CFO Brian Van Wagener stated that "Second quarter results exceeded guidance on all metrics and our view for the full year improved across the board." For the fiscal third quarter, Veeva expects total revenues between $932 million and $935 million, with non-GAAP fully diluted net income per share between $2.33 and $2.34. The company also updated its full-year fiscal 2027 guidance, projecting total revenues between $3,682 million and $3,687 million and non-GAAP fully diluted net income per share of approximately $9.21, signaling continued strong performance.

💬 Key Quote

"AI is opening up the next big chapter for Veeva and life sciences." — Peter Gassner, CEO

🏢 About Veeva Systems

Veeva Systems (VEEV) is a publicly listed company on the NYSE exchange in the Technology sector. EarningsBloom tracks its quarterly earnings calls to provide free AI-generated summaries for investors.

VEEV NYSE Technology All Veeva Systems Summaries →

📈 Want to act on this insight?

🇮🇳 Open Zerodha Account 🌱 Start with Groww 📄 Full Transcript on Seeking Alpha 📚 Learn Financial Analysis

Topics: Cloud Software Life Sciences Artificial Intelligence Enterprise CRM

📁 More from Veeva Systems

View all earnings summaries for Veeva Systems →